EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieOpen Access

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

Richard J Auchus, Oksana Hamidi, Rosario Pivonello, Irina Bancos, Gianni Russo, Selma F Witchel, Andrea M Isidori, Patrice Rodien, Umasuthan Srirangalingam, Florian W Kiefer, Henrik Falhammar iD, Deborah P Merke iD und 9 weitere

New England Journal of Medicine · 08.08.2024 · 391 (6) · 504-514

DOI: 10.1056/nejmoa2404656 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 08.08.2024. Verfasst von Richard J Auchus und 20 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical Schoo…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Androstenedione, Amines, Thiazoles. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Neurocrine Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalAndrostenedioneAminesThiazolesAdultFemaleHumansMaleYoung AdultDose-Response Relationship, DrugDouble-Blind MethodGlucocorticoidsHydrocortisoneReceptors, Corticotropin-Releasing HormoneDrug Therapy, CombinationFatigueHeadacheCRF Receptor, Type 1

Substanzen

AndrostenedioneGlucocorticoidsHydrocortisonecrinecerfontAminesThiazolesCRF Receptor, Type 1Receptors, Corticotropin-Releasing Hormone

Autor:innen und Institutionen

  • From the Departments of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, and the Endocrinology and Metabolism Section, Medicine Service, Lie…

ORCID-Profile: Henrik Falhammar, Deborah P Merke

Förderung

  • NIDDK NIH HHS
  • Neurocrine Biosciences

Zitieren

APA

Auchus, R. J., Hamidi, O., Pivonello, R., Bancos, I., Russo, G., Witchel, S. F., Isidori, A. M., Rodien, P., Srirangalingam, U., Kiefer, F. W., Falhammar, H., Merke, D. P., Reisch, N., Sarafoglou, K., Cutler, G. B., Sturgeon, J., Roberts, E., Lin, V. H., Chan, J. L., …, & CAHtalyst Adult Trial Investigators (2024). Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. New England Journal of Medicine, 391(6), 504-514. https://doi.org/10.1056/nejmoa2404656

Vancouver

Auchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, et al. Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. New England Journal of Medicine. 2024;391(6):504-514. doi:10.1056/nejmoa2404656

BibTeX
@article{Auchus2024,
  author = {Auchus, Richard J and Hamidi, Oksana and Pivonello, Rosario and Bancos, Irina and Russo, Gianni and Witchel, Selma F and Isidori, Andrea M and Rodien, Patrice and Srirangalingam, Umasuthan and Kiefer, Florian W and Falhammar, Henrik and Merke, Deborah P and Reisch, Nicole and Sarafoglou, Kyriakie and Cutler, Gordon B and Sturgeon, Julia and Roberts, Eiry and Lin, Vivian H and Chan, Jean L and Farber, Robert H and CAHtalyst Adult Trial Investigators, CAHtalyst Adult Trial Investigators},
  title = {Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {6},
  pages = {504--514},
  doi = {10.1056/nejmoa2404656}
}
Kostenlos starten →